USD 27.0
(-3.98%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 7.42 Million USD | 60.61% |
2023 | 4.62 Million USD | 28.36% |
2022 | 3.6 Million USD | -4.0% |
2021 | 3.75 Million USD | -35.97% |
2020 | 5.85 Million USD | 56.45% |
2019 | 3.74 Million USD | -1.44% |
2018 | 3.79 Million USD | -12.16% |
2017 | 4.32 Million USD | 12.38% |
2016 | 3.84 Million USD | 88.04% |
2015 | 2.04 Million USD | 6367.15% |
2014 | -32.65 Thousand USD | 97.33% |
2013 | -1.23 Million USD | -206.41% |
2012 | 1.14 Million USD | -50.53% |
2011 | 2.33 Million USD | 7.67% |
2010 | 2.14 Million USD | -22.61% |
2009 | 2.77 Million USD | 343.6% |
2008 | 627.43 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 356 Thousand USD | -78.87% |
2024 Q2 | 2.47 Million USD | 594.38% |
2024 Q3 | 2.04 Million USD | -17.11% |
2024 FY | - USD | 60.61% |
2024 Q4 | 2.54 Million USD | 24.21% |
2023 Q3 | 1.29 Million USD | 1.96% |
2023 Q4 | 1.68 Million USD | 29.72% |
2023 FY | - USD | 28.36% |
2023 Q1 | 198 Thousand USD | -59.76% |
2023 Q2 | 1.27 Million USD | 543.43% |
2022 Q3 | 1.03 Million USD | -14.94% |
2022 Q4 | 492 Thousand USD | -52.51% |
2022 Q2 | 1.21 Million USD | 75.0% |
2022 Q1 | 696 Thousand USD | 6.75% |
2022 FY | - USD | -4.0% |
2021 Q2 | 1.58 Million USD | 91.52% |
2021 Q4 | 652 Thousand USD | 69.41% |
2021 FY | - USD | -35.97% |
2021 Q1 | 826.41 Thousand USD | -35.94% |
2021 Q3 | 384.86 Thousand USD | -75.68% |
2020 Q4 | 1.29 Million USD | 17.86% |
2020 Q3 | 1.09 Million USD | -38.0% |
2020 Q2 | 1.76 Million USD | 15.41% |
2020 Q1 | 1.52 Million USD | 2.96% |
2020 FY | - USD | 56.45% |
2019 FY | - USD | -1.44% |
2019 Q4 | 1.48 Million USD | 115.56% |
2019 Q1 | 393.64 Thousand USD | -75.26% |
2019 Q2 | 867.31 Thousand USD | 120.33% |
2019 Q3 | 689.16 Thousand USD | -20.54% |
2018 Q4 | 1.59 Million USD | 134.05% |
2018 FY | - USD | -12.16% |
2018 Q3 | 679.74 Thousand USD | -30.14% |
2018 Q2 | 973.06 Thousand USD | 167.12% |
2018 Q1 | 364.27 Thousand USD | -75.94% |
2017 FY | - USD | 12.38% |
2017 Q2 | 923.01 Thousand USD | 92.82% |
2017 Q3 | 1.23 Million USD | 33.51% |
2017 Q4 | 1.51 Million USD | 22.88% |
2017 Q1 | 478.7 Thousand USD | -11.17% |
2016 Q4 | 538.87 Thousand USD | -41.57% |
2016 Q3 | 922.28 Thousand USD | -35.8% |
2016 Q1 | 771.31 Thousand USD | 89.4% |
2016 Q2 | 1.43 Million USD | 86.26% |
2016 FY | - USD | 88.04% |
2015 Q2 | 633 Thousand USD | 8.13% |
2015 Q1 | 585.42 Thousand USD | 3.49% |
2015 Q4 | 407.24 Thousand USD | 66.27% |
2015 Q3 | 244.93 Thousand USD | -61.31% |
2015 FY | - USD | 6367.15% |
2014 FY | - USD | 97.33% |
2014 Q1 | -415.26 Thousand USD | -49.36% |
2014 Q4 | 565.67 Thousand USD | 1733.1% |
2014 Q2 | -141.02 Thousand USD | 66.04% |
2014 Q3 | -34.63 Thousand USD | 75.44% |
2013 Q2 | -430.88 Thousand USD | -919.52% |
2013 Q1 | 52.57 Thousand USD | 131.27% |
2013 Q3 | -549.19 Thousand USD | -27.46% |
2013 Q4 | -278.02 Thousand USD | 49.38% |
2013 FY | - USD | -206.41% |
2012 Q3 | 363.07 Thousand USD | 53.04% |
2012 Q2 | 237.23 Thousand USD | -58.6% |
2012 FY | - USD | -50.53% |
2012 Q4 | -168.16 Thousand USD | -146.32% |
2012 Q1 | 573.02 Thousand USD | 10.62% |
2011 Q4 | 517.99 Thousand USD | -34.25% |
2011 Q2 | 659.44 Thousand USD | 86.21% |
2011 Q1 | 354.13 Thousand USD | -5.95% |
2011 Q3 | 787.8 Thousand USD | 19.47% |
2011 FY | - USD | 7.67% |
2010 FY | - USD | -22.61% |
2010 Q2 | 257.61 Thousand USD | -63.51% |
2010 Q3 | 854.42 Thousand USD | 231.67% |
2010 Q4 | 376.54 Thousand USD | -55.93% |
2010 Q1 | 705.96 Thousand USD | 29.17% |
2009 Q4 | 546.52 Thousand USD | 0.0% |
2009 FY | - USD | 343.6% |
2008 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Myomo, Inc. | -8.06 Million USD | 192.002% |
Senseonics Holdings, Inc. | -48 Million USD | 115.461% |
Catheter Precision, Inc. | -15.11 Million USD | 149.12% |
Xtant Medical Holdings, Inc. | -6.98 Million USD | 206.271% |